6378 related articles for article (PubMed ID: 2822596)
21. Effects of brequinar and ciprofloxacin on de novo nucleotide biosynthesis in mouse L1210 leukemia.
Lyons SD; Christopherson RI
Biochem Int; 1990 Dec; 22(6):939-49. PubMed ID: 1965281
[TBL] [Abstract][Full Text] [Related]
22. Influence of ammonium ions on hepatic de novo pyrimidine biosynthesis.
Monks A; Chisena CA; Cysyk RL
Arch Biochem Biophys; 1985 Jan; 236(1):1-10. PubMed ID: 2981502
[TBL] [Abstract][Full Text] [Related]
23. Human spleen dihydroorotate dehydrogenase: a study of inhibition of the enzyme.
Gero AM; O'Sullivan WJ; Brown DJ
Biochem Med; 1985 Aug; 34(1):60-9. PubMed ID: 2996510
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationship of quinoline carboxylic acids. A new class of inhibitors of dihydroorotate dehydrogenase.
Chen SF; Papp LM; Ardecky RJ; Rao GV; Hesson DP; Forbes M; Dexter DL
Biochem Pharmacol; 1990 Aug; 40(4):709-14. PubMed ID: 2386542
[TBL] [Abstract][Full Text] [Related]
25. Site of action of two novel pyrimidine biosynthesis inhibitors accurately predicted by the compare program.
Cleaveland ES; Monks A; Vaigro-Wolff A; Zaharevitz DW; Paull K; Ardalan K; Cooney DA; Ford H
Biochem Pharmacol; 1995 Mar; 49(7):947-54. PubMed ID: 7741767
[TBL] [Abstract][Full Text] [Related]
26. Uracil nucleotide synthesis in a human breast cancer cell line (MCF-7) and in two drug-resistant sublines that contain increased levels of enzymes of the de novo pyrimidine pathway.
Karle JM; Cowan KH; Chisena CA; Cysyk RL
Mol Pharmacol; 1986 Aug; 30(2):136-41. PubMed ID: 2874477
[TBL] [Abstract][Full Text] [Related]
27. Effect of plasma concentrations of uridine on pyrimidine biosynthesis in cultured L1210 cells.
Karle JM; Anderson LW; Cysyk RL
J Biol Chem; 1984 Jan; 259(1):67-72. PubMed ID: 6323418
[TBL] [Abstract][Full Text] [Related]
28. The relationship between dihydroorotic acid dehydrogenase and in vitro and in vivo cytostatic effects of brequinar sodium (DUP-785; NSC 368390).
Peters GJ; Laurensse E; de Kant E; Nadal JC; Pinedo HM
Adv Exp Med Biol; 1989; 253B():375-82. PubMed ID: 2558540
[No Abstract] [Full Text] [Related]
29. Biological activity and mode of action of some dihydroorotic and dihydroazaorotic acid derivatives.
Miersch J; Grancharov K; Krauss GJ; Spassovska N; Karamanov G; Maneva L; Mladenova J; Golovinsky E
Biomed Biochim Acta; 1987; 46(5):307-15. PubMed ID: 3663203
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic effects of dihydroorotase inhibitors upon human CCRF-CEM leukemia.
Brooke J; Szabados E; Lyons SD; Goodridge RJ; Harsanyi MC; Poiner A; Christopherson RI
Cancer Res; 1990 Dec; 50(24):7793-8. PubMed ID: 1979249
[TBL] [Abstract][Full Text] [Related]
31. Alteration in de novo pyrimidine biosynthesis during uridine reversal of pyrazofurin-inhibited DNA synthesis.
Ringer DP; Howell BA; Etheredge JL
J Biochem Toxicol; 1991; 6(1):19-27. PubMed ID: 1880786
[TBL] [Abstract][Full Text] [Related]
32. Effects of acivicin and dichloroallyl lawsone upon pyrimidine biosynthesis in mouse L1210 leukemia cells.
Kemp AJ; Lyons SD; Christopherson RI
J Biol Chem; 1986 Nov; 261(32):14891-5. PubMed ID: 3771555
[TBL] [Abstract][Full Text] [Related]
33. The "anti-pyrimidine effect" of hypoxia and brequinar sodium (NSC 368390) is of consequence for tumor cell growth.
Löffler M
Biochem Pharmacol; 1992 May; 43(10):2281-7. PubMed ID: 1599514
[TBL] [Abstract][Full Text] [Related]
34. Analogues of carbamyl aspartate as inhibitors of dihydroorotase: preparation of boronic acid transition-state analogues and a zinc chelator carbamylhomocysteine.
Kinder DH; Frank SK; Ames MM
J Med Chem; 1990 Feb; 33(2):819-23. PubMed ID: 1967653
[TBL] [Abstract][Full Text] [Related]
35. Biochemical genetic analysis of pyrimidine biosynthesis in mammalian cells. II. Isolation and characterization of a mutant of Chinese hamster ovary cells with defective dihydroorotate dehydrogenase (E.C. 1.3.3.1) activity.
Stamato TD; Patterson D
J Cell Physiol; 1979 Mar; 98(3):459-68. PubMed ID: 220270
[TBL] [Abstract][Full Text] [Related]
36. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.
Moyer JD; Handschumacher RE
Cancer Res; 1979 Aug; 39(8):3089-94. PubMed ID: 455293
[No Abstract] [Full Text] [Related]
38. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
[TBL] [Abstract][Full Text] [Related]
39. Orotic Acid, More Than Just an Intermediate of Pyrimidine de novo Synthesis.
Löffler M; Carrey EA; Zameitat E
J Genet Genomics; 2015 May; 42(5):207-19. PubMed ID: 26059769
[TBL] [Abstract][Full Text] [Related]
40. Synergistic effects with inhibitors of de novo pyrimidine synthesis, acivicin, and N-(phosphonacetyl)-L-aspartic acid.
Loh E; Kufe DW
Cancer Res; 1981 Sep; 41(9 Pt 1):3419-23. PubMed ID: 7260907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
